0MSD Stock Overview Provides e-health services worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteCompuGroup Medical SE & Co. KGaA Competitors Price History & Performance
Summary of share price highs, lows and changes for CompuGroup Medical SE KGaA Historical stock prices Current Share Price €21.62 52 Week High €40.78 52 Week Low €13.16 Beta 0.84 1 Month Change 52.84% 3 Month Change 61.37% 1 Year Change -42.00% 3 Year Change -68.90% 5 Year Change -66.58% Change since IPO 483.11%
Recent News & Updates Funds advised and managed by affiliates of CVC Capital Partners plc (ENXTAM:CVC) launched voluntary public tender offer to acquire unknown minority stake in CompuGroup Medical SE & Co. KGaA (XTRA:COP) from The founding family Gotthardt, Reinhard Koop, Gt 1 VermÖGensverwaltung GmbH and others in a going private transaction for a transaction valuing at approximately €1.2 billion.
New major risk - Share price stability Dec 09 Funds advised and managed by affiliates of CVC Capital Partners plc (ENXTAM:CVC) launched voluntary public tender offer to acquire unknown minority stake in CompuGroup Medical SE & Co. KGaA (XTRA:COP) from The founding family Gotthardt, Reinhard Koop, Gt 1 VermÖGensverwaltung GmbH and others in a going private transaction for a transaction valuing at €1.2 billion. Dec 09
CompuGroup Medical SE & Co. KGaA to Report Q2, 2025 Results on Jul 31, 2025
Third quarter 2024 earnings released: EPS: €0.17 (vs €0.30 in 3Q 2023) Nov 08 CompuGroup Medical SE & Co. KGaA Announces CEO Changes See more updates Funds advised and managed by affiliates of CVC Capital Partners plc (ENXTAM:CVC) launched voluntary public tender offer to acquire unknown minority stake in CompuGroup Medical SE & Co. KGaA (XTRA:COP) from The founding family Gotthardt, Reinhard Koop, Gt 1 VermÖGensverwaltung GmbH and others in a going private transaction for a transaction valuing at approximately €1.2 billion.
New major risk - Share price stability Dec 09 Funds advised and managed by affiliates of CVC Capital Partners plc (ENXTAM:CVC) launched voluntary public tender offer to acquire unknown minority stake in CompuGroup Medical SE & Co. KGaA (XTRA:COP) from The founding family Gotthardt, Reinhard Koop, Gt 1 VermÖGensverwaltung GmbH and others in a going private transaction for a transaction valuing at €1.2 billion. Dec 09
CompuGroup Medical SE & Co. KGaA to Report Q2, 2025 Results on Jul 31, 2025
Third quarter 2024 earnings released: EPS: €0.17 (vs €0.30 in 3Q 2023) Nov 08 CompuGroup Medical SE & Co. KGaA Announces CEO Changes
Second quarter 2024 earnings released: EPS: €0.27 (vs €0.60 in 2Q 2023) Jul 16
Investor sentiment deteriorates as stock falls 29% Jul 09
CompuGroup Medical SE & Co. KGaA (XTRA:COP) acquired AmbulApps GmbH. Jun 19
Upcoming dividend of €1.00 per share May 16
First quarter 2024 earnings released: EPS: €0.35 (vs €0.28 in 1Q 2023) May 08 CompuGroup Medical SE & Co. KGaA Proposes Dividend for the Year 2023 Apr 11
Full year 2023 earnings released: EPS: €0.88 (vs €1.41 in FY 2022) Mar 30
CompuGroup Medical SE & Co. KGaA Announces Chief Executive Officer for the US Changes Mar 26
Dividend of €1.00 announced Feb 23
Full year 2023 earnings released: EPS: €0.88 (vs €1.41 in FY 2022) Feb 08
Investor sentiment deteriorates as stock falls 16% Feb 08
Third quarter 2023 earnings released: EPS: €0.31 (vs €0.56 in 3Q 2022) Nov 10 CompuGroup Medical SE & Co. KGaA to Report Q3, 2024 Results on Nov 07, 2024 CompuGroup Medical SE & Co. KGaA Appoints Daniela Hommel as Chief Financial Officer, Effective March 2024
Second quarter 2023 earnings released: EPS: €0.60 (vs €0.23 in 2Q 2022) Aug 11
Compugroup Medical Se & Co. KGaa Appoints Michael Rauch as CEO May 18
Upcoming dividend of €0.50 per share at 1.0% yield May 12 CompuGroup Medical SE & Co. KGaA Confirms Revenue Guidance for 2023 May 11
First quarter 2023 earnings released: EPS: €0.28 (vs €0.35 in 1Q 2022) May 10
Full year 2022 earnings released: EPS: €1.41 (vs €1.30 in FY 2021) Mar 27
Full year 2022 earnings released: EPS: €1.41 (vs €1.30 in FY 2021) Feb 10
CompuGroup Medical SE & Co. KGaA to Report Q4, 2022 Results on Feb 09, 2023 Feb 08
CompuGroup Medical SE & Co. KGaA to Report First Half, 2023 Results on Aug 10, 2023 Dec 30
CompuGroup Medical SE & Co. KGaA (XTRA:COP) acquired 20% stake in New Line Ricerche Di Mercato Societa' Benefit Spa. Dec 15
CompuGroup Medical SE & Co. KGaA (XTRA:COP) agreed to acquire GHG business operations of Gotthardt Healthgroup Holding Gmbh. Nov 24 CompuGroup Medical SE & Co. KGaA (XTRA:COP) agreed to acquire GHG business operations of Gotthardt Healthgroup Holding Gmbh.
Investor sentiment improved over the past week Nov 11
Third quarter 2022 earnings released: EPS: €0.56 (vs €0.54 in 3Q 2021) Nov 04
CompuGroup Medical SE & Co. KGaA, Annual General Meeting, May 17, 2023 Nov 04
Second quarter 2022 earnings released: EPS: €0.23 (vs €0.33 in 2Q 2021) Aug 05
CompuGroup Medical SE & Co. KGaA Revises Earnings Guidance for the Year 2022 Aug 05
Investor sentiment deteriorated over the past week Jun 13 CompuGroup Medical SE & Co. KGaA Announces CEO Dirk Wössner Decides to End His Contract as of June 30, 2022 CompuGroup Medical SE & Co. KGaA Announces CEO Dirk Wössner Decides to End His Contract as of June 30, 2022
CompuGroup Medical SE & Co. KGaA Provides Revenue Guidance for the Year 2022 May 20
Upcoming dividend of €0.50 per share May 13
First quarter 2022 earnings released: EPS: €0.35 (vs €0.20 in 1Q 2021) May 06
Full year 2021 earnings released: EPS: €1.30 (vs €1.43 in FY 2020) Apr 10
CompuGroup Medical SE & Co. KGaA Proposes 2021 Dividend Apr 08 CompuGroup Medical SE & Co. KGaA to Report Q3, 2022 Results on Nov 03, 2022
CompuGroup Medical SE & Co. KGaA appoints ngela Mazza Teufer to the Management Board Feb 16
Now 23% undervalued after recent price drop Feb 04
CompuGroup Medical SE & Co. KGaA Provides Revenue Guidance for the Fiscal Year 2021 and 2022 Jan 19
Now 20% undervalued after recent price drop Jan 18
Third quarter 2021 earnings released: EPS €0.54 (vs €0.67 in 3Q 2020) Nov 05
CompuGroup Medical SE & Co. KGaA Confirms Earnings Guidance for the Year 2021 Sep 15
Second quarter 2021 earnings released: EPS €0.33 (vs €0.34 in 2Q 2020) Aug 06
CompuGroup Medical SE & Co. KGaA Provides Earnings Guidance for the Full Year of 2021 Aug 06
CompuGroup Medical SE & Co. KGaA (XTRA:COP) acquired Meta IT GmbH. Jun 09
CompuGroup Medical SE & Co. KGaA (XTRA:COP) acquired Visus Health It Gmbh. Jun 02
Upcoming dividend of €0.50 per share May 13
First quarter 2021 earnings released: EPS €0.20 (vs €0.26 in 1Q 2020) May 11
CompuGroup Medical SE & Co. KGaA Confirms Earnings Guidance for the Year 2021 May 08
Investor sentiment deteriorated over the past week May 07
Full year 2020 earnings released: EPS €1.43 (vs €1.35 in FY 2019) Mar 28
New 90-day low: €70.88 Feb 24
New 90-day high: €83.45 Jan 21
Third quarter 2020 earnings released: EPS €0.67 Nov 11
Revenue beats expectations Nov 11
New 90-day high: €82.00 Nov 07
Third quarter 2020 earnings released: EPS €0.67 Nov 07
Revenue beats expectations Nov 07
New 90-day high - €77.35 Aug 25
First half earnings released Aug 07
Compugroup Medical SE & Co. KGaA has completed a Follow-on Equity Offering in the amount of €340.60384 million. Jun 30 Shareholder Returns 0MSD GB Healthcare Services GB Market 7D 0.1% -5.6% -2.6% 1Y -42.0% 13.9% 2.4%
See full shareholder returns
Return vs Market: 0MSD underperformed the UK Market which returned 2.4% over the past year.
Price Volatility Is 0MSD's price volatile compared to industry and market? 0MSD volatility 0MSD Average Weekly Movement 10.4% Healthcare Services Industry Average Movement 6.1% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0MSD's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0MSD's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company Founded Employees CEO Website 1987 8,412 Daniel Gotthardt www.cgm.com
CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations.
Show more CompuGroup Medical SE & Co. KGaA Fundamentals Summary How do CompuGroup Medical SE KGaA's earnings and revenue compare to its market cap? 0MSD fundamental statistics Market cap €1.12b Earnings (TTM ) €25.17m Revenue (TTM ) €1.19b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0MSD income statement (TTM ) Revenue €1.19b Cost of Revenue €808.71m Gross Profit €380.68m Other Expenses €355.51m Earnings €25.17m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 06, 2025
Earnings per share (EPS) 0.49 Gross Margin 32.01% Net Profit Margin 2.12% Debt/Equity Ratio 125.7%
How did 0MSD perform over the long term?
See historical performance and comparison Dividends
4.6% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 02:53 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources CompuGroup Medical SE & Co. KGaA is covered by 19 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Gerhard Schwarz Baader Helvea Equity Research Knut Woller Baader Helvea Equity Research Gunnar Cohrs Berenberg
Show 16 more analysts